NCCN Categories of Evidence and Consensus
Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2A: Based upon lower-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2B: Based upon lower-level evidence, there is NCCN consensus that the intervention is appropriate.
Category 3: Based upon any level of evidence, there is major NCCN disagreement that the intervention is appropriate.
All recommendations are category 2A unless otherwise noted.
Clinical trials: NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged.
Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol 2012;30:3687–3696.
Raphael J, Hester J, Ahmedzai S et al.. Cancer pain: part 2: physical, interventional and complimentary therapies; management in the community; acute, treatment-related and complex cancer pain: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med 2010;11:872–896.
- Search Google Scholar
- Export Citation
. Raphael J Hester J Ahmedzai S Cancer pain: part 2: physical, interventional and complimentary therapies; management in the community; acute, treatment-related and complex cancer pain: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med 2010; 11: 872– 896.
van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG et al.. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007;18:1437–1449.
Hicks CL, von Baeyer CL, Spafford PA et al.. The Faces of Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain 2001;93:173–183.
Serlin RC, Mendoza TR, Nakamura Y et al.. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995;61:277–284.
Soetenga D, Frank J, Pellino TA. Assessment of the validity and reliability of the University of Wisconsin Children’s Hospital Pain scale for Preverbal and Nonverbal Children. Pediatr Nurs 1999;25:670–676.
Ware LJ, Epps CD, Herr K, Packard A. Evaluation of the revised faces pain scale, verbal descriptor scale, numeric rating scale, and Iowa pain thermometer in older minority adults. Pain Manag Nurs 2006;7:117–125.
Crew KD, Greenlee H, Capodice J et al.. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 2007;25:3877–3883.
Caraceni A, Zecca E, Bonezzi C et al.. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 2004;22:2909–2917.
Jongen JL, Huijsman ML, Jessurun J et al.. The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects. J Pain Symptom Manage 2013.
Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2011:CD007938.
Koyyalagunta D, Bruera E, Solanki DR et al.. A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician 2012;15:ES39–58.
Akbik H, Butler SF, Budman SH et al.. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage 2006;32:287–293.
Butler SF, Fernandez K, Benoit C et al.. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain 2008;9:360–372.
Chou R, Fanciullo GJ, Fine PG et al.. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:131–146.
- Search Google Scholar
- Export Citation
. Chou R Fanciullo GJ Fine PG Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009; 10: 131– 146.
Passik SD, Kirsh KL. The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse. Exp Clin Psychopharmacol 2008;16:400–404.
Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 2005;6:432–442.
Transmucosal immediate release fentanyl (TIRF) risk evaluation and mitigation strateby (REMS). Available at: http://www.fda.gov/downloads/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm289730.pdf. Accessed November 21, 2013.
Bennett MI. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review. Palliat Med 2010.
Smith EM, Pang H, Cirrincione C et al.. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013;309:1359–1367.
Baron R, Brunnmuller U, Brasser M et al.. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: open-label, non-comparative, flexible-dose study. Eur J Pain 2008;12:850–858.
Johannessen Landmark C. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs 2008;22:27–47.
Leppert W, Buss T. The role of corticosteroids in the treatment of pain in cancer patients. Curr Pain Headache Rep 2012;16:307–313.
Mercadante SL, Berchovich M, Casuccio A et al.. A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. Am J Hosp Palliat Care 2007;24:13–19.
Wooldridge JE, Anderson CM, Perry MC. Corticosteroids in advanced cancer. Oncology (Williston Park) 2001;15:225–234; discussion 234-236.
Nabal M, Librada S, Redondo MJ et al.. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer: a systematic review of the literature. Palliat Med 2012;26:305–312.
Richards BL, Whittle SL, Buchbinder R. Muscle relaxants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev 2012;1:CD008922.
Richards BL, Whittle SL, van der Heijde DM, Buchbinder R. The efficacy and safety of muscle relaxants in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl 2012;90:34–39.
Cassileth BR, Keefe FJ. Integrative and behavioral approaches to the treatment of cancer-related neuropathic pain. Oncologist 2010;15 Suppl 2:19–23.
Huang ST, Good M, Zauszniewski JA. The effectiveness of music in relieving pain in cancer patients: a randomized controlled trial. Int J Nurs Stud 2010;47:1354–1362.
Kwekkeboom KL, Cherwin CH, Lee JW, Wanta B. Mind-body treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer. J Pain Symptom Manage 2010;39:126–138.
Montgomery GH, Weltz CR, Seltz M, Bovbjerg DH. Brief presurgery hypnosis reduces distress and pain in excisional breast biopsy patients. Int J Clin Exp Hypn 2002;50:17–32.
Pfister DG, Cassileth BR, Deng GE et al.. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol 2010;28:2565–2570.
Stoelb BL, Molton IR, Jensen MP, Patterson DR. The efficacy of hypnotic analgesia in adults: a review of the literature. Contemp Hypn 2009;26:24–39.
Keefe FJ, Abernethy AP, Campbell LC. Psychological approaches to understanding and treating disease-related pain. Annu Rev Psychol 2005;56:601–630.
Sheinfeld Gorin S, Krebs P, Badr H et al.. Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. J Clin Oncol 2012;30:539–547.
Johannsen M, Farver I, Beck N, Zachariae R. The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: a systematic review and meta-analysis. Breast Cancer Res Treat 2013;138:675–690.
Carvalho AP, Vital FM, Soares BG. Exercise interventions for shoulder dysfunction in patients treated for head and neck cancer. Cochrane Database Syst Rev 2012;4:CD008693.
Mishra SI, Scherer RW, Geigle PM et al.. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev 2012;8:CD007566.
Cantarero-Villanueva I, Fernandez-Lao C, Fernandez-de-Las-Penas C et al.. Effectiveness of water physical therapy on pain, pressure pain sensitivity, and myofascial trigger points in breast cancer survivors: a randomized, controlled clinical trial. Pain Med 2012;13:1509–1519.
- Search Google Scholar
- Export Citation
. Cantarero-Villanueva I Fernandez-Lao C Fernandez-de-Las-Penas C Effectiveness of water physical therapy on pain, pressure pain sensitivity, and myofascial trigger points in breast cancer survivors: a randomized, controlled clinical trial. Pain Med 2012; 13: 1509– 1519.
Fernandez-Lao C, Cantarero-Villanueva I, Fernandez-de-Las-Penas C et al.. Effectiveness of a multidimensional physical therapy program on pain, pressure hypersensitivity, and trigger points in breast cancer survivors: a randomized controlled clinical trial. Clin J Pain 2012;28:113–121.
- Search Google Scholar
- Export Citation
. Fernandez-Lao C Cantarero-Villanueva I Fernandez-de-Las-Penas C Effectiveness of a multidimensional physical therapy program on pain, pressure hypersensitivity, and trigger points in breast cancer survivors: a randomized controlled clinical trial. Clin J Pain 2012; 28: 113– 121.
McNeely ML, Parliament MB, Seikaly H et al.. Effect of exercise on upper extremity pain and dysfunction in head and neck cancer survivors: a randomized controlled trial. Cancer 2008;113:214–222.
Rajotte EJ, Yi JC, Baker KS et al.. Community-based exercise program effectiveness and safety for cancer survivors. J Cancer Surviv 2012;6:219–228.
Barros GA, Miot HA, Braz AM et al.. Topical (S)-ketamine for pain management of postherpetic neuralgia. An Bras Dermatol 2012;87:504–505.
Hempenstall K, Nurmikko TJ, Johnson RW et al.. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2005;2:e164.
Ho KY, Huh BK, White WD et al.. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain. Clin J Pain 2008;24:51–55.
Lin PL, Fan SZ, Huang CH et al.. Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: a double-blind and vehicle-controlled study. Reg Anesth Pain Med 2008;33:320–325.
Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain 2005;6:644–649.
Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology 2005;103:140–146.
Kopsky DJ, Hesselink JM. High doses of topical amitriptyline in neuropathic pain: two cases and literature review. Pain Pract 2012;12:148–153.
Fleming JA, O’Connor BD. Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre. Pain Res Manag 2009;14:381–388.
Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol 2003;43:111–117.
Hurlow A, Bennett MI, Robb KA et al.. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database Syst Rev 2012;3:CD006276.
Choi TY, Lee MS, Kim TH et al.. Acupuncture for the treatment of cancer pain: a systematic review of randomised clinical trials. Support Care Cancer 2012;20:1147–1158.
Garcia MK, McQuade J, Haddad R et al.. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol 2013;31:952–960.